Immunosuppression underlies resistance to anti-angiogenic therapy
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...
Jul 14, 2017